Silicon containing detectable compounds

US12331199B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12331199-B2
Application numberUS-202318130212-A
CountryUS
Kind codeB2
Filing dateApr 3, 2023
Priority dateMay 18, 2018
Publication dateJun 17, 2025
Grant dateJun 17, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein, inter alia, are silicon containing detectable compounds and methods of use thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound, or salt thereof, having the formula: wherein, L 3 is L 1 -L 2 -comprises R 1 is substituted or unsubstituted alkyl, halogen, —CF 3 , —CBr 3 , —CCl 3 , —CI 3 , —CHF 2 , —CHBr 2 , —CHCl 2 , —CHI 2 , —CH 2 F, —CH 2 Br, —CH 2 Cl, —CH 2 I, —OH, —NH 2 , —COOH, —CONH 2 , —SH, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 2 and R 3 are independently substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; R 4 is hydrogen, R 34 -substituted or unsubstituted alkyl, halogen, —CF 3 , —CBr 3 , —CCl 3 , —CI 3 , —CHF 2 , —CHBr 2 , —CHCl 2 , —CHI 2 , —CH 2 F, —CH 2 Br, —CH 2 Cl, —CH 2 I, —OH, —NH 2 , —COOH, —CONH 2 , —SH, R 34 -substituted or unsubstituted heteroalkyl, R 34 -substituted or unsubstituted cycloalkyl, or R 34 -substituted or unsubstituted heterocycloalkyl; R 5 is hydrogen, R 35 -substituted or unsubstituted alkyl, halogen, —CF 3 , —CBr 3 , —CCl 3 , —CI 3 , —CHF 2 , —CHBr 2 , —CHCl 2 , —CHI 2 , —CH 2 F, —CH 2 Br, —CH 2 Cl, —CH 2 I, —OH, —NH 2 , —COOH, —CONH 2 , —SH, R 35 -substituted or unsubstituted heteroalkyl, R 35 -substituted or unsubstituted cycloalkyl, or R 35 -substituted or unsubstituted heterocycloalkyl; R 6 is hydrogen, R 36 -substituted or unsubstituted alkyl, halogen, —CF 3 , —CBr 3 , —CCl 3 , —CI 3 , —CHF 2 , —CHBr 2 , —CHCl 2 , —CHI 2 , —CH 2 F, —CH 2 Br, —CH 2 Cl, —CH 2 I, —OH, —NH 2 , —COOH, —CONH 2 , —SH, R 36 -substituted or unsubstituted heteroalkyl, R 36 -substituted or unsubstituted cycloalkyl, or R 36 -substituted or unsubstituted heterocycloalkyl; R 7 is hydrogen, R 37 -substituted or unsubstituted alkyl, halogen, —CF 3 , —CBr 3 , —CCl 3 , —CI 3 , —CHF 2 , —CHBr 2 , —CHCl 2 , —CHI 2 , —CH 2 F, —CH 2 Br, —CH 2 Cl, —CH 2 I, —OH, —NH 2 , —COOH, —CONH 2 , —SH, R 37 -substituted or unsubstituted heteroalkyl, R 37 -substituted or unsubstituted cycloalkyl, or R 37 -substituted or unsubstituted heterocycloalkyl; R 8 is a nucleotide; R 9 is hydrogen, R 39 -substituted or unsubstituted alkyl, or R 39 -substituted or unsubstituted heteroalkyl; R 10 is hydrogen, R 40 -substituted or unsubstituted alkyl, or R 40 -substituted or unsubstituted heteroalkyl; R 11 is hydrogen, R 41 -substituted or unsubstituted alkyl, or R 41 -substituted or unsubstituted heteroalkyl; R 12 is hydrogen, R 42 -substituted or unsubstituted alkyl, or R 42 -substituted or unsubstituted heteroalkyl; R 4 and R 5 substituents bonded to the same nitrogen atom may optionally be joined to form a R 34 -substituted or unsubstituted heterocycloalkyl; R 6 and R 7 substituents bonded to the same nitrogen atom may optionally be joined to form a R 36 -substituted or unsubstituted heterocycloalkyl; R 4 and R 9 substituents may optionally be joined to form a R 34 -substituted or unsubstituted heterocycloalkyl, or R 39 -substituted or unsubstituted heteroaryl; R 7 and R 10 substituents may optionally be joined to form a R 37 -substituted or unsubstituted heterocycloalkyl, or R 37 -substituted or unsubstituted heteroaryl; R 5 and R 11 substituents may optionally be joined to form a R 35 -substituted or unsubstituted heterocycloalkyl, or R 35 -substituted or unsubstituted heteroaryl; R 6 and R 12 substituents may optionally be joined to form a R 36 -substituted or unsubstituted heterocycloalkyl, or R 36 -substituted or unsubstituted heteroaryl; R 34 is independently oxo, halogen, —CF 3 , —CCl 3 , —CI 3 , —CBr 3 , —CHF 2 , —CHCl 2 , —CHI 2 , —CHBr 2 , —CH 2 F, —CH 2 Cl, —CH 2 I, —CH 2 Br, —OCH 2 F, —OCH 2 Cl, —OCH 2 I, —OCH 2 Br, —OCHF 2 , —OCHCl 2 , —OCHI 2 , —OCHBr 2 , —OCF 3 , —OCCl 3 , —OCI 3 , —OCBr 3 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC═(O)NHNH 2 , —NHC═(O)NH 2 , —NHSO 2 H, —NHC═(O)H, —NHC(O)OH, —NHOH, —PO 4 H, —PO 3 H, —N 3 , unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, or unsubstituted heterocycloalkyl; R 35 is independently oxo, halogen, —CF 3 , —CCl 3 , —CI 3 , —CBr 3 , —CHF 2 , —CHCl 2 , —CHI 2 , —CHBr 2 , —CH 2 F, —CH 2 Cl, —CH 2 I, —CH 2 Br, —OCH 2 F, —OCH 2 Cl, —OCH 2 I, —OCH 2 Br, —OCHF 2 , —OCHCl 2 , —OCHI 2 , —OCHBr 2 , —OCF 3 , —OCCl 3 , —OCI 3 , —OCBr 3 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC═(O)NHNH 2 , —NHC═(O)NH 2 , —NHSO 2 H, —NHC═(O)H, —NHC(O)OH, —NHOH, —PO 4 H, —PO 3 H, —N 3 , unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, or unsubstituted heterocycloalkyl; R 36 is independently oxo, halogen, —CF 3 , —CCl 3 , —CI 3 , —CBr 3 , —CHF 2 , —CHCl 2 , —CHI 2 , —CHBr 2 , —CH 2 F, —CH 2 Cl, —CH 2 I, —CH 2 Br, —OCH 2 F, —OCH 2 Cl, —OCH 2 I, —OCH 2 Br, —OCHF 2 , —OCHCl 2 , —OCHI 2 , —OCHBr 2 , —OCF 3 , —OCCl 3 , —OCI 3 , —OCBr 3 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC═(O)NHNH 2 , —NHC═(O)NH 2 , —NHSO 2 H, —NHC═(O)H, —NHC(O)OH, —NHOH, —PO 4 H, —PO 3 H, —N 3 , unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, or unsubstituted heterocycloalkyl; R 37 is independently oxo, halogen, —CF 3 , —CCl 3 , —CI 3 , —CBr 3 , —CHF 2 , —CHCl 2 , —CHI 2 , —CHBr 2 , —CH 2 F, —CH 2 Cl, —CH 2 I, —CH 2 Br, —OCH 2 F, —OCH 2 Cl, —OCH 2 I, —OCH 2 Br, —OCHF 2 , —OCHCl 2 , —OCHI 2 , —OCHBr 2 , —OCF 3 , —OCCl 3 , —OCI 3 , —OCBr 3 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC═(O)NHNH 2 , —NHC═(O)NH 2 , —NHSO 2 H, —NHC═(O)H, —NHC(O)OH, —NHOH, —PO 4 H, —PO 3 H, —N 3 , unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, or unsubstituted heterocycloalkyl; R 39 is independently —PO 3 H, —PO 4 H, —SO 2 NH 2 , —SO 3 H, or —SO 4 H; R 40 is independently —PO 3 H, —PO 4 H, —SO 2 NH 2 , —SO 3 H, or —SO 4 H; R 41 is independently —PO 3 H, —PO 4 H, —SO 2 NH 2 , —SO 3 H, or —SO 4 H; and R 42 is independently —PO 3 H, —PO 4 H, —SO 2 NH 2 , —SO 3 H, or —SO 4 H. 2. The compound of claim 1 , wherein R 1 is substituted or unsubstituted C 1 -C 6 alkyl. 3. The compound of claim 1 , wherein R 2 and R 3 are independently substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted 2 to 6 membered heteroalkyl. 4. The compound of claim 1 , wherein R 4 is hydrogen, R 34 -substituted or unsubstituted C 1 -C 6 alkyl, or R 34 -substituted or unsubstituted 2 to 6 membered heteroalkyl; R 5 is hydrogen, R 35 -substituted or unsubstituted C 1 -C 6 alkyl, or R 35 -substituted or unsubstituted 2 to 6 membered heteroalkyl; R 6 is hydrogen, R 36 -substituted or unsubstituted C 1 -C 6 alkyl, or R 36 -substituted or unsubstituted 2 to 6 membered heteroalkyl; and R 7 is hydrogen, R 37 -substituted or unsubstituted C 1 -C 6 alkyl, or R 37 -substituted or unsubstituted 2 to 6 membered heteroalkyl. 5. The compound of claim 1 , wherein R 4 and R 5 substituents bonded to the same nitrogen atom are joined to form a R 34 -substituted or unsubstituted 5 membered heterocycloalkyl or R 34 -substituted or unsubstituted 6 membered heterocycloalkyl. 6. The compound of claim 1 , wherein R 6 and R 7 substituents b

Assignees

Inventors

Classifications

  • with ribosyl as saccharide radical · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • Preparations of compounds not comprising Si-Si or Si-cyano linkages · CPC title

  • Syntheses without formation of a Si-C bond · CPC title

  • Compounds with Si-C or Si-Si linkages · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12331199B2 cover?
Disclosed herein, inter alia, are silicon containing detectable compounds and methods of use thereof.
Who is the assignee on this patent?
Singular Genomics Systems Inc
What technology area does this patent fall under?
Primary CPC classification C07F7/0816. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).